25 XP   0   0   10

Zhejiang Huahai Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Huahai Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Huahai Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Huahai Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Huahai Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Huahai Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Huahai Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Huahai Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.09
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥5.57
Expected worth in 1 year
¥6.19
How sure are you?
92.5%

+ What do you gain per year?

Total Gains per Share
¥1.27
Return On Investment
9.8%

For what price can you sell your share?

Current Price per Share
¥12.92
Expected price per share
¥10.71 - ¥14.14
How sure are you?
50%

1. Valuation of Zhejiang Huahai Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥12.92

Intrinsic Value Per Share

¥-2.00 - ¥1.06

Total Value Per Share

¥3.57 - ¥6.63

2. Growth of Zhejiang Huahai Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Huahai Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$981.6m$138.8m12.4%

How much money is Zhejiang Huahai Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$37.8m$23.9m$13.9m36.8%
Net Profit Margin12.4%8.8%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Huahai Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Huahai Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Huahai Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Huahai Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Huahai Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Huahai Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Huahai Pharmaceutical Co Ltd is ¥12.92. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Huahai Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Huahai Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.57. Based on the TTM, the Book Value Change Per Share is ¥0.15 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.16 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Huahai Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.030.2%0.020.1%0.020.1%0.010.1%
Usd Book Value Change Per Share-0.02-0.1%0.020.2%0.010.1%0.010.1%0.010.1%
Usd Dividend Per Share0.020.1%0.020.2%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.000.0%0.040.3%0.020.1%0.020.2%0.020.2%
Usd Price Per Share2.35-2.68-2.93-2.94-2.98-
Price to Earnings Ratio41.13-24.77-7.19-36.52-61.41-
Price-to-Total Gains Ratio-2,151.88--500.28-50.63-754.31-464.08-
Price to Book Ratio3.04-3.56-4.44-4.86-6.39-
Price-to-Total Gains Ratio-2,151.88--500.28-50.63-754.31-464.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.788128
Number of shares559
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.040.02
Gains per Quarter (559 shares)24.5913.91
Gains per Year (559 shares)98.3655.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1514888243246
2101951864764102
31521432847196158
420219138294128214
5253239480118160270
6304286578142192326
7354334676165224382
8405382774189256438
9456430872212289494
10506477970236321550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%38.02.00.095.0%81.02.00.097.6%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%15.05.00.075.0%32.08.00.080.0%72.011.00.086.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%79.00.04.095.2%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%17.03.00.085.0%37.03.00.092.5%80.03.00.096.4%

Fundamentals of Zhejiang Huahai Pharmaceutical Co Ltd

About Zhejiang Huahai Pharmaceutical Co Ltd

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. The company was founded in 1989 and is headquartered in Linhai, China.

Fundamental data was last updated by Penke on 2024-03-26 18:13:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Huahai Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Huahai Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Huahai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 8.0% means that ¥0.08 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The MRQ is 8.0%. The company is making a profit. +1
  • The TTM is 12.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ8.0%TTM12.4%-4.4%
TTM12.4%YOY8.8%+3.6%
TTM12.4%5Y10.5%+1.8%
5Y10.5%10Y10.9%-0.4%
1.1.2. Return on Assets

Shows how efficient Zhejiang Huahai Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Huahai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.8% Return on Assets means that Zhejiang Huahai Pharmaceutical Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.8%TTM1.5%-0.6%
TTM1.5%YOY1.1%+0.4%
TTM1.5%5Y1.3%+0.2%
5Y1.3%10Y1.5%-0.2%
1.1.3. Return on Equity

Shows how efficient Zhejiang Huahai Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Huahai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.9% Return on Equity means Zhejiang Huahai Pharmaceutical Co Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The MRQ is 1.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.9%TTM3.5%-1.6%
TTM3.5%YOY2.4%+1.0%
TTM3.5%5Y2.8%+0.7%
5Y2.8%10Y2.8%+0.0%

1.2. Operating Efficiency of Zhejiang Huahai Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Huahai Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Huahai Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Huahai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM9.6%-9.6%
TTM9.6%YOY13.0%-3.4%
TTM9.6%5Y13.3%-3.7%
5Y13.3%10Y7.2%+6.1%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Huahai Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.28 means that the operating costs are ¥1.28 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The MRQ is 1.276. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.194. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.276TTM1.194+0.082
TTM1.194YOY1.244-0.050
TTM1.1945Y1.222-0.028
5Y1.22210Y0.882+0.340

1.3. Liquidity of Zhejiang Huahai Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Huahai Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.63 means the company has ¥1.63 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The MRQ is 1.629. The company is able to pay all its short-term debts. +1
  • The TTM is 1.627. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.629TTM1.627+0.003
TTM1.627YOY1.742-0.115
TTM1.6275Y1.641-0.015
5Y1.64110Y0.895+0.746
1.3.2. Quick Ratio

Measures if Zhejiang Huahai Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Huahai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.59 means the company can pay off ¥0.59 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The MRQ is 0.587. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.567. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.587TTM0.567+0.020
TTM0.567YOY0.536+0.031
TTM0.5675Y0.494+0.073
5Y0.49410Y0.569-0.074

1.4. Solvency of Zhejiang Huahai Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Huahai Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Huahai Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.55 means that Zhejiang Huahai Pharmaceutical Co Ltd assets are financed with 55.2% credit (debt) and the remaining percentage (100% - 55.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The MRQ is 0.552. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.567. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.552TTM0.567-0.015
TTM0.567YOY0.560+0.007
TTM0.5675Y0.531+0.036
5Y0.53110Y0.439+0.092
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Huahai Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Huahai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 126.0% means that company has ¥1.26 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The MRQ is 1.260. The company is able to pay all its debts with equity. +1
  • The TTM is 1.343. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.260TTM1.343-0.083
TTM1.343YOY1.314+0.028
TTM1.3435Y1.193+0.150
5Y1.19310Y0.877+0.316

2. Market Valuation of Zhejiang Huahai Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Huahai Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Huahai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 41.13 means the investor is paying ¥41.13 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The EOD is 31.351. Based on the earnings, the company is overpriced. -1
  • The MRQ is 41.130. Based on the earnings, the company is overpriced. -1
  • The TTM is 24.765. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD31.351MRQ41.130-9.779
MRQ41.130TTM24.765+16.365
TTM24.765YOY7.189+17.577
TTM24.7655Y36.523-11.758
5Y36.52310Y61.412-24.888
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The EOD is 20.232. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 26.543. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -14.833. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD20.232MRQ26.543-6.311
MRQ26.543TTM-14.833+41.376
TTM-14.833YOY-27.743+12.910
TTM-14.8335Y-140.693+125.861
5Y-140.69310Y-80.691-60.002
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Huahai Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Huahai Pharmaceutical Co Ltd:

  • The EOD is 2.320. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.044. Based on the equity, the company is fair priced.
  • The TTM is 3.558. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.320MRQ3.044-0.724
MRQ3.044TTM3.558-0.514
TTM3.558YOY4.442-0.884
TTM3.5585Y4.859-1.301
5Y4.85910Y6.390-1.531
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Huahai Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1350.154-187%0.070-293%0.104-230%0.089-251%
Book Value Per Share--5.5685.459+2%4.768+17%4.430+26%3.586+55%
Current Ratio--1.6291.627+0%1.742-6%1.641-1%0.895+82%
Debt To Asset Ratio--0.5520.567-3%0.560-1%0.531+4%0.439+26%
Debt To Equity Ratio--1.2601.343-6%1.314-4%1.193+6%0.877+44%
Dividend Per Share--0.1270.164-23%0.048+162%0.076+66%0.082+54%
Eps--0.1030.222-54%0.117-12%0.133-23%0.1030%
Free Cash Flow Per Share--0.1600.020+712%-0.249+256%-0.048+130%-0.084+152%
Free Cash Flow To Equity Per Share--0.160-0.007+104%-0.196+223%0.009+1761%0.044+260%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1.060--------
Intrinsic Value_10Y_min---2.001--------
Intrinsic Value_1Y_max---0.271--------
Intrinsic Value_1Y_min---0.476--------
Intrinsic Value_3Y_max---0.526--------
Intrinsic Value_3Y_min---1.200--------
Intrinsic Value_5Y_max---0.435--------
Intrinsic Value_5Y_min---1.666--------
Market Cap19154028579.840-31%25128543686.40028693001654.443-12%31448996545.573-20%31492287693.832-20%31890310302.983-21%
Net Profit Margin--0.0800.124-35%0.088-9%0.105-24%0.109-27%
Operating Margin---0.096-100%0.130-100%0.133-100%0.072-100%
Operating Ratio--1.2761.194+7%1.244+3%1.222+4%0.882+45%
Pb Ratio2.320-31%3.0443.558-14%4.442-31%4.859-37%6.390-52%
Pe Ratio31.351-31%41.13024.765+66%7.189+472%36.523+13%61.412-33%
Price Per Share12.920-31%16.95019.348-12%21.140-20%21.221-20%21.500-21%
Price To Free Cash Flow Ratio20.232-31%26.543-14.833+156%-27.743+205%-140.693+630%-80.691+404%
Price To Total Gains Ratio-1640.252+24%-2151.878-500.276-77%50.630-4350%754.308-385%464.077-564%
Quick Ratio--0.5870.567+3%0.536+9%0.494+19%0.569+3%
Return On Assets--0.0080.015-43%0.011-21%0.013-36%0.015-46%
Return On Equity--0.0190.035-45%0.024-22%0.028-33%0.028-32%
Total Gains Per Share---0.0080.318-102%0.118-107%0.180-104%0.172-105%
Usd Book Value--1142460897.8471120508266.202+2%981611567.253+16%910046794.271+26%736350854.188+55%
Usd Book Value Change Per Share---0.0190.021-187%0.010-293%0.014-230%0.012-251%
Usd Book Value Per Share--0.7710.756+2%0.660+17%0.613+26%0.496+55%
Usd Dividend Per Share--0.0180.023-23%0.007+162%0.011+66%0.011+54%
Usd Eps--0.0140.031-54%0.016-12%0.018-23%0.0140%
Usd Free Cash Flow--32755904.8534027701.954+713%-51292774.983+257%-9848525.175+130%-15027050.308+146%
Usd Free Cash Flow Per Share--0.0220.003+712%-0.034+256%-0.007+130%-0.012+152%
Usd Free Cash Flow To Equity Per Share--0.022-0.001+104%-0.027+223%0.001+1761%0.006+260%
Usd Market Cap2650917555.450-31%3477790446.1983971111428.975-12%4352541121.907-20%4358532616.826-20%4413618945.933-21%
Usd Price Per Share1.788-31%2.3462.678-12%2.926-20%2.937-20%2.976-21%
Usd Profit--21138787.29437879960.583-44%23958267.152-12%25800497.115-18%20436346.859+3%
Usd Revenue--264819340.317298783392.504-11%272780051.131-3%236954260.137+12%186684841.502+42%
Usd Total Gains Per Share---0.0010.044-102%0.016-107%0.025-104%0.024-105%
 EOD+5 -3MRQTTM+14 -21YOY+15 -205Y+14 -2110Y+17 -18

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Huahai Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1531.351
Price to Book Ratio (EOD)Between0-12.320
Net Profit Margin (MRQ)Greater than00.080
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.587
Current Ratio (MRQ)Greater than11.629
Debt to Asset Ratio (MRQ)Less than10.552
Debt to Equity Ratio (MRQ)Less than11.260
Return on Equity (MRQ)Greater than0.150.019
Return on Assets (MRQ)Greater than0.050.008
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Huahai Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.123
Ma 20Greater thanMa 5013.585
Ma 50Greater thanMa 10013.220
Ma 100Greater thanMa 20014.200
OpenGreater thanClose12.760
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Interest Income  6,96739,37346,340-36,32910,01123,94833,958-91,327-57,369



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets18,431,421
Total Liabilities10,176,646
Total Stockholder Equity8,076,555
 As reported
Total Liabilities 10,176,646
Total Stockholder Equity+ 8,076,555
Total Assets = 18,431,421

Assets

Total Assets18,431,421
Total Current Assets7,646,145
Long-term Assets10,785,276
Total Current Assets
Cash And Cash Equivalents 1,089,956
Short-term Investments 85,635
Net Receivables 2,666,647
Inventory 3,519,023
Other Current Assets 101,944
Total Current Assets  (as reported)7,646,145
Total Current Assets  (calculated)7,463,204
+/- 182,941
Long-term Assets
Property Plant Equipment 7,813,361
Goodwill 70,902
Intangible Assets 1,879,341
Long-term Assets Other 365
Long-term Assets  (as reported)10,785,276
Long-term Assets  (calculated)9,763,969
+/- 1,021,307

Liabilities & Shareholders' Equity

Total Current Liabilities4,692,584
Long-term Liabilities5,484,061
Total Stockholder Equity8,076,555
Total Current Liabilities
Short Long Term Debt 1,525,863
Accounts payable 1,349,367
Other Current Liabilities 1,344
Total Current Liabilities  (as reported)4,692,584
Total Current Liabilities  (calculated)2,876,574
+/- 1,816,010
Long-term Liabilities
Long term Debt 4,582,800
Capital Lease Obligations Min Short Term Debt47,984
Long-term Liabilities Other 171,213
Long-term Liabilities  (as reported)5,484,061
Long-term Liabilities  (calculated)4,801,997
+/- 682,065
Total Stockholder Equity
Retained Earnings 4,614,137
Total Stockholder Equity (as reported)8,076,555
Total Stockholder Equity (calculated)4,614,137
+/- 3,462,418
Other
Capital Stock1,482,507
Common Stock Shares Outstanding 1,482,507
Net Debt 5,018,707
Net Invested Capital 14,185,218
Net Working Capital 2,953,561
Property Plant and Equipment Gross 7,813,361



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312001-12-312000-12-31
> Total Assets 
178,018
223,875
248,182
743,523
725,699
755,902
774,685
767,808
794,176
826,387
895,552
903,857
903,446
880,982
975,044
1,076,815
1,045,310
1,091,096
1,098,060
1,138,168
1,270,514
1,232,206
1,263,299
1,293,946
1,417,390
1,434,156
1,517,558
1,590,966
1,622,604
1,726,287
1,735,249
1,835,749
1,845,144
1,904,949
2,054,267
2,047,856
2,227,477
2,387,853
2,577,028
2,611,900
2,942,560
3,032,473
3,216,612
3,571,114
4,313,327
4,305,820
4,466,104
4,707,006
4,227,424
4,368,184
4,510,016
4,767,052
4,990,923
5,438,565
5,515,496
5,881,050
6,126,488
6,671,687
6,726,384
7,065,626
7,467,789
7,751,372
8,266,827
8,813,050
9,565,254
9,886,850
10,367,491
10,924,909
11,247,520
11,796,551
10,729,345
10,565,255
11,298,288
11,935,547
12,990,766
12,945,125
14,518,564
14,767,728
15,468,125
15,920,304
16,171,803
16,891,397
18,151,737
18,694,368
19,549,707
18,431,421
18,431,42119,549,70718,694,36818,151,73716,891,39716,171,80315,920,30415,468,12514,767,72814,518,56412,945,12512,990,76611,935,54711,298,28810,565,25510,729,34511,796,55111,247,52010,924,90910,367,4919,886,8509,565,2548,813,0508,266,8277,751,3727,467,7897,065,6266,726,3846,671,6876,126,4885,881,0505,515,4965,438,5654,990,9234,767,0524,510,0164,368,1844,227,4244,707,0064,466,1044,305,8204,313,3273,571,1143,216,6123,032,4732,942,5602,611,9002,577,0282,387,8532,227,4772,047,8562,054,2671,904,9491,845,1441,835,7491,735,2491,726,2871,622,6041,590,9661,517,5581,434,1561,417,3901,293,9461,263,2991,232,2061,270,5141,138,1681,098,0601,091,0961,045,3101,076,815975,044880,982903,446903,857895,552826,387794,176767,808774,685755,902725,699743,523248,182223,875178,018
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,899,537
4,990,401
5,212,456
5,694,650
5,912,757
6,433,064
5,266,692
5,014,893
5,466,956
5,724,042
6,523,112
6,110,789
7,220,283
6,802,791
6,812,609
6,886,762
6,843,826
7,196,597
7,907,176
8,180,537
8,797,780
7,646,145
7,646,1458,797,7808,180,5377,907,1767,196,5976,843,8266,886,7626,812,6096,802,7917,220,2836,110,7896,523,1125,724,0425,466,9565,014,8935,266,6926,433,0645,912,7575,694,6505,212,4564,990,4014,899,5370000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,010,895
778,111
910,815
1,489,157
1,796,933
2,485,102
1,504,459
1,264,455
1,312,120
1,474,650
2,211,854
1,703,432
2,750,534
2,318,319
1,876,302
1,737,065
1,310,468
1,297,990
1,365,153
1,728,715
1,924,457
1,089,956
1,089,9561,924,4571,728,7151,365,1531,297,9901,310,4681,737,0651,876,3022,318,3192,750,5341,703,4322,211,8541,474,6501,312,1201,264,4551,504,4592,485,1021,796,9331,489,157910,815778,1111,010,8950000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
0
0
0
0
0
0
0
3,079
156
1,012
0
264
0
143,069
112,014
85,724
85,635
85,63585,724112,014143,069026401,0121563,07900000002600000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
39,410
29,053
28,307
38,493
43,361
57,819
152,026
71,903
108,282
96,450
93,264
102,251
112,738
99,217
119,527
123,513
138,928
113,173
142,565
150,306
194,653
179,256
151,838
159,271
211,787
175,835
162,884
170,376
179,765
208,835
214,444
223,230
208,514
217,279
288,352
308,356
376,127
398,112
410,440
404,603
442,545
433,834
528,270
602,471
647,356
696,158
762,914
807,803
689,242
742,322
824,947
812,769
972,378
942,349
1,091,772
1,187,313
1,268,302
1,207,109
1,321,994
1,494,535
1,534,940
1,509,314
1,666,225
1,844,749
1,835,329
1,984,266
1,979,369
1,827,210
1,709,428
1,496,286
1,424,124
1,549,435
1,845,739
1,731,590
1,796,996
1,729,859
1,629,830
1,538,226
1,946,584
1,913,491
2,231,204
2,447,565
2,665,335
2,628,668
2,941,226
2,666,647
2,666,6472,941,2262,628,6682,665,3352,447,5652,231,2041,913,4911,946,5841,538,2261,629,8301,729,8591,796,9961,731,5901,845,7391,549,4351,424,1241,496,2861,709,4281,827,2101,979,3691,984,2661,835,3291,844,7491,666,2251,509,3141,534,9401,494,5351,321,9941,207,1091,268,3021,187,3131,091,772942,349972,378812,769824,947742,322689,242807,803762,914696,158647,356602,471528,270433,834442,545404,603410,440398,112376,127308,356288,352217,279208,514223,230214,444208,835179,765170,376162,884175,835211,787159,271151,838179,256194,653150,306142,565113,173138,928123,513119,52799,217112,738102,25193,26496,450108,28271,903152,02657,81943,36138,49328,30729,05339,410
       Other Current Assets 
440
422
681
156
1,586
1,777
885
3,871
7,344
1,031
31,227
33,864
25,008
31,135
25,903
28,903
28,915
30,248
25,434
32,067
34,281
35,394
34,184
43,923
40,256
52,952
32,747
44,539
31,677
40,244
6,359
7,792
9,795
15,546
35,084
75,334
82,471
86,653
10,590
15,377
38,833
37,339
17,464
17,903
46,766
59,667
501,290
545,636
25,757
142,169
42,017
74,578
47,897
68,883
60,736
145,613
78,454
86,797
67,540
148,062
92,662
128,916
120,812
147,011
128,247
132,895
137,464
86,632
102,513
87,619
119,067
153,078
120,597
137,062
145,837
183,455
193,951
245,141
250,183
317,926
150,613
165,143
72,969
111,423
395,178
101,944
101,944395,178111,42372,969165,143150,613317,926250,183245,141193,951183,455145,837137,062120,597153,078119,06787,619102,51386,632137,464132,895128,247147,011120,812128,91692,662148,06267,54086,79778,454145,61360,73668,88347,89774,57842,017142,16925,757545,636501,29059,66746,76617,90317,46437,33938,83315,37710,59086,65382,47175,33435,08415,5469,7957,7926,35940,24431,67744,53932,74752,95240,25643,92334,18435,39434,28132,06725,43430,24828,91528,90325,90331,13525,00833,86431,2271,0317,3443,8718851,7771,586156681422440
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,230,259
5,334,762
5,363,487
5,462,653
5,550,362
5,831,332
6,211,505
6,467,655
6,834,336
7,298,281
7,964,938
8,655,516
9,033,543
9,327,977
9,694,800
10,244,562
10,513,831
10,751,928
10,785,276
10,785,27610,751,92810,513,83110,244,5629,694,8009,327,9779,033,5438,655,5167,964,9387,298,2816,834,3366,467,6556,211,5055,831,3325,550,3625,462,6535,363,4875,334,7625,230,2590000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
51,788
80,195
121,463
126,773
130,366
152,694
158,667
172,439
189,575
204,862
243,615
252,439
312,057
347,145
481,542
410,244
517,661
453,585
558,487
434,404
610,362
463,969
568,481
498,351
603,332
523,487
655,285
577,659
691,338
613,503
713,269
655,600
776,354
700,309
894,161
842,316
970,630
911,801
1,157,146
1,126,412
1,285,756
1,285,887
1,467,645
1,328,896
1,608,497
1,445,595
1,710,744
1,556,320
1,611,985
1,656,562
1,722,541
1,810,963
1,941,245
2,009,973
2,094,086
2,157,214
2,263,247
2,361,198
2,561,108
2,702,538
2,760,633
2,861,886
2,938,284
3,057,130
3,156,579
3,310,032
3,523,830
3,586,846
3,668,683
3,765,382
3,803,032
3,878,315
4,014,922
4,183,781
4,366,100
4,686,210
4,906,035
5,572,599
5,960,842
6,305,298
6,654,188
6,959,995
7,306,986
7,529,350
7,727,761
7,813,361
7,813,3617,727,7617,529,3507,306,9866,959,9956,654,1886,305,2985,960,8425,572,5994,906,0354,686,2104,366,1004,183,7814,014,9223,878,3153,803,0323,765,3823,668,6833,586,8463,523,8303,310,0323,156,5793,057,1302,938,2842,861,8862,760,6332,702,5382,561,1082,361,1982,263,2472,157,2142,094,0862,009,9731,941,2451,810,9631,722,5411,656,5621,611,9851,556,3201,710,7441,445,5951,608,4971,328,8961,467,6451,285,8871,285,7561,126,4121,157,146911,801970,630842,316894,161700,309776,354655,600713,269613,503691,338577,659655,285523,487603,332498,351568,481463,969610,362434,404558,487453,585517,661410,244481,542347,145312,057252,439243,615204,862189,575172,439158,667152,694130,366126,773121,46380,19551,788
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,835
32,835
32,835
32,835
32,835
65,919
65,919
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,902
70,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90270,90265,91965,91932,83532,83532,83532,83532,83500000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
485,327
492,123
508,973
504,715
503,433
409,881
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000409,881503,433504,715508,973492,123485,3270000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
4,985
4,876
4,744
4,711
4,893
4,868
4,842
4,800
4,818
4,778
14,652
14,518
68
26,396
38
89,479
13
88,778
113
156,830
638
155,532
637
95,820
469
94,569
7,033
100,151
8,093
100,342
15,010
106,170
16,996
114,732
16,784
113,917
17,408
117,959
19,190
124,097
23,876
153,822
25,577
271,591
24,547
299,229
24,323
291,457
290,411
289,880
360,495
358,385
449,461
445,170
464,212
519,139
513,407
511,920
501,539
496,272
498,407
496,583
632,986
628,728
555,504
614,163
618,487
879,524
903,305
918,251
948,196
961,614
1,061,598
1,181,769
1,186,345
1,222,618
1,236,787
1,277,466
1,472,479
1,507,076
1,560,416
1,622,858
1,783,751
1,827,665
1,871,276
1,879,341
1,879,3411,871,2761,827,6651,783,7511,622,8581,560,4161,507,0761,472,4791,277,4661,236,7871,222,6181,186,3451,181,7691,061,598961,614948,196918,251903,305879,524618,487614,163555,504628,728632,986496,583498,407496,272501,539511,920513,407519,139464,212445,170449,461358,385360,495289,880290,411291,45724,323299,22924,547271,59125,577153,82223,876124,09719,190117,95917,408113,91716,784114,73216,996106,17015,010100,3428,093100,1517,03394,56946995,820637155,532638156,83011388,7781389,4793826,3966814,51814,6524,7784,8184,8004,8424,8684,8934,7114,7444,8764,985
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
164,123
172,669
49,743
9,797
11,332
24,930
4,199,011
17,433
17,438
19,028
41,287
743
366
441
18,729
2,782
1,652
233
365
3652331,6522,78218,72944136674341,28719,02817,43817,4334,199,01124,93011,3329,79749,743172,669164,1230000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
112,791
151,725
167,624
121,295
86,169
96,806
89,267
53,918
67,306
60,333
110,026
87,358
84,919
105,704
172,705
241,656
206,431
231,286
222,659
236,012
364,623
286,527
287,783
287,464
388,250
387,431
414,511
447,063
502,229
576,886
522,981
583,090
607,043
638,277
735,923
685,824
843,161
929,818
1,047,469
990,573
1,220,383
1,247,488
1,267,573
1,513,949
1,425,229
1,353,457
1,446,818
1,633,297
1,234,487
1,150,741
1,243,941
1,368,861
1,545,084
1,872,707
1,795,142
2,026,255
2,014,760
2,422,500
2,148,552
2,353,848
2,791,159
2,875,379
3,212,103
3,596,739
4,468,371
4,703,888
6,160,710
6,582,637
6,681,333
6,077,111
4,950,606
4,550,725
5,173,802
5,575,773
6,266,664
5,966,770
7,548,516
7,797,700
8,691,801
9,002,636
8,840,395
9,546,521
10,406,116
10,764,516
11,095,323
10,176,646
10,176,64611,095,32310,764,51610,406,1169,546,5218,840,3959,002,6368,691,8017,797,7007,548,5165,966,7706,266,6645,575,7735,173,8024,550,7254,950,6066,077,1116,681,3336,582,6376,160,7104,703,8884,468,3713,596,7393,212,1032,875,3792,791,1592,353,8482,148,5522,422,5002,014,7602,026,2551,795,1421,872,7071,545,0841,368,8611,243,9411,150,7411,234,4871,633,2971,446,8181,353,4571,425,2291,513,9491,267,5731,247,4881,220,383990,5731,047,469929,818843,161685,824735,923638,277607,043583,090522,981576,886502,229447,063414,511387,431388,250287,464287,783286,527364,623236,012222,659231,286206,431241,656172,705105,70484,91987,358110,02660,33367,30653,91889,26796,80686,169121,295167,624151,725112,791
   > Total Current Liabilities 
84,291
91,725
117,624
121,295
82,569
86,406
78,867
43,518
56,905
46,155
95,848
73,180
70,741
91,527
158,527
227,479
192,253
221,908
212,921
226,228
353,438
275,343
284,006
283,686
384,472
383,653
410,734
393,285
358,451
433,109
349,203
389,312
403,266
454,499
697,925
604,736
805,074
891,171
1,009,591
952,695
1,152,790
1,202,189
1,221,964
1,468,784
1,337,729
1,265,111
1,360,127
1,546,933
1,147,080
1,107,739
1,196,996
1,322,636
1,481,111
1,747,069
1,682,477
1,914,448
1,870,196
2,281,610
1,513,743
1,720,047
2,058,527
2,043,862
2,835,089
3,225,192
3,247,960
3,376,144
4,766,261
4,913,205
5,744,262
5,072,949
3,356,989
2,716,407
3,529,367
4,007,107
2,890,933
2,572,202
3,851,608
3,573,241
4,235,566
3,804,631
3,650,306
4,301,601
4,798,554
4,958,142
5,570,817
4,692,584
4,692,5845,570,8174,958,1424,798,5544,301,6013,650,3063,804,6314,235,5663,573,2413,851,6082,572,2022,890,9334,007,1073,529,3672,716,4073,356,9895,072,9495,744,2624,913,2054,766,2613,376,1443,247,9603,225,1922,835,0892,043,8622,058,5271,720,0471,513,7432,281,6101,870,1961,914,4481,682,4771,747,0691,481,1111,322,6361,196,9961,107,7391,147,0801,546,9331,360,1271,265,1111,337,7291,468,7841,221,9641,202,1891,152,790952,6951,009,591891,171805,074604,736697,925454,499403,266389,312349,203433,109358,451393,285410,734383,653384,472283,686284,006275,343353,438226,228212,921221,908192,253227,479158,52791,52770,74173,18095,84846,15556,90543,51878,86786,40682,569121,295117,62491,72584,291
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
92,632
220,134
233,349
2,777,264
2,948,098
3,057,126
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003,057,1262,948,0982,777,264233,349220,13492,6320000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
92,632
220,134
233,349
2,777,264
2,948,098
3,057,126
1,417,371
1,062,994
2,060,299
2,417,135
1,004,748
872,803
1,585,290
1,273,145
1,313,818
1,152,169
606,928
1,189,801
1,396,598
1,685,991
2,206,333
1,525,863
1,525,8632,206,3331,685,9911,396,5981,189,801606,9281,152,1691,313,8181,273,1451,585,290872,8031,004,7482,417,1352,060,2991,062,9941,417,3713,057,1262,948,0982,777,264233,349220,13492,6320000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
9,531
12,771
27,023
28,963
14,131
14,436
12,146
14,349
19,564
9,691
45,513
37,784
27,247
35,600
51,065
49,594
91,570
78,885
38,366
26,568
36,497
40,689
76,864
87,376
82,518
91,735
156,645
144,598
246,532
242,770
117,238
135,299
123,147
149,760
181,788
210,251
273,834
289,275
340,781
347,428
390,507
387,768
407,795
418,991
385,108
390,592
357,737
291,870
301,246
380,728
468,002
421,077
525,994
501,345
576,860
563,082
631,526
662,719
760,431
682,791
610,678
683,789
759,416
769,038
765,166
739,926
662,582
625,285
616,098
719,707
577,039
534,218
761,721
871,204
894,342
852,508
868,851
811,955
881,786
931,321
998,875
980,770
1,202,616
1,198,287
1,284,076
1,349,367
1,349,3671,284,0761,198,2871,202,616980,770998,875931,321881,786811,955868,851852,508894,342871,204761,721534,218577,039719,707616,098625,285662,582739,926765,166769,038759,416683,789610,678682,791760,431662,719631,526563,082576,860501,345525,994421,077468,002380,728301,246291,870357,737390,592385,108418,991407,795387,768390,507347,428340,781289,275273,834210,251181,788149,760123,147135,299117,238242,770246,532144,598156,64591,73582,51887,37676,86440,68936,49726,56838,36678,88591,57049,59451,06535,60027,24737,78445,5139,69119,56414,34912,14614,43614,13128,96327,02312,7719,531
       Other Current Liabilities 
56,940
53,954
90,601
92,332
68,438
71,970
66,721
29,169
37,341
36,464
50,335
35,396
43,494
35,927
57,462
47,885
30,683
43,023
64,555
49,660
41,941
54,654
52,701
46,310
51,954
41,918
54,089
48,687
61,919
140,339
211,965
250,570
276,676
301,296
326,067
137,085
119,319
108,602
120,796
102,006
285,571
300,572
349,984
317,919
371,459
387,168
482,511
134,554
123,582
125,865
229,155
159,142
173,548
169,259
261,794
184,591
196,771
422,253
286,783
222,045
251,150
265,967
515,895
274,988
256,387
275,252
1,147,312
134,670
839,494
843,458
347,125
540,743
322,280
597,382
396,207
594,779
476,310
779,205
603,547
1,022,010
507,474
1,114,479
7,020
4,743
512,877
1,344
1,344512,8774,7437,0201,114,479507,4741,022,010603,547779,205476,310594,779396,207597,382322,280540,743347,125843,458839,494134,6701,147,312275,252256,387274,988515,895265,967251,150222,045286,783422,253196,771184,591261,794169,259173,548159,142229,155125,865123,582134,554482,511387,168371,459317,919349,984300,572285,571102,006120,796108,602119,319137,085326,067301,296276,676250,570211,965140,33961,91948,68754,08941,91851,95446,31052,70154,65441,94149,66064,55543,02330,68347,88557,46235,92743,49435,39650,33536,46437,34129,16966,72171,97068,43892,33290,60153,95456,940
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,669,432
937,071
1,004,161
1,593,616
1,834,318
1,644,434
1,568,667
3,375,731
3,394,569
3,696,908
4,224,459
4,456,235
5,198,005
5,190,089
5,244,920
5,607,562
5,806,374
5,524,506
5,484,061
5,484,0615,524,5065,806,3745,607,5625,244,9205,190,0895,198,0054,456,2354,224,4593,696,9083,394,5693,375,7311,568,6671,644,4341,834,3181,593,6161,004,161937,0711,669,4320000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
3,600
10,400
10,400
10,400
10,401
14,178
14,178
14,178
14,178
14,177
14,178
14,177
14,178
9,378
9,738
9,737
11,138
11,137
3,777
3,778
3,778
3,778
3,777
3,778
3,778
3,777
3,778
23,778
33,777
33,778
37,998
38,088
38,087
38,647
37,878
37,878
37,593
45,299
45,609
45,165
43,631
44,695
43,403
42,684
43,722
43,002
43,711
42,991
63,687
125,352
112,422
111,563
111,165
107,257
99,923
99,103
96,943
105,661
154,691
157,592
188,079
427,744
494,448
473,432
443,071
510,161
414,423
410,372
414,714
434,858
454,657
451,711
715,551
735,421
891,956
874,395
771,435
815,481
0
914,638
797,823
0
0797,823914,6380815,481771,435874,395891,956735,421715,551451,711454,657434,858414,714410,372414,423510,161443,071473,432494,448427,744188,079157,592154,691105,66196,94399,10399,923107,257111,165111,563112,422125,35263,68742,99143,71143,00243,72242,68443,40344,69543,63145,16545,60945,29937,59337,87837,87838,64738,08738,08837,99833,77833,77723,7783,7783,7773,7783,7783,7773,7783,7783,7783,77711,13711,1389,7379,7389,37814,17814,17714,17814,17714,17814,17814,17814,17810,40110,40010,40010,4003,6000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
189,927
230,942
249,369
272,768
305,933
327,401
310,799
318,770
344,887
385,222
387,697
429,306
433,887
485,479
508,280
542,700
603,141
655,304
0
0
767,114
0
0767,11400655,304603,141542,700508,280485,479433,887429,306387,697385,222344,887318,770310,799327,401305,933272,768249,369230,942189,9270000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
64,463
72,009
80,440
622,109
639,407
658,973
685,290
713,758
726,725
765,251
784,402
815,397
815,159
771,967
798,935
831,778
835,990
856,798
872,356
899,162
902,802
930,593
960,451
991,704
1,014,238
1,031,942
1,088,334
1,123,077
1,099,790
1,129,070
1,191,840
1,232,283
1,219,750
1,248,334
1,296,986
1,358,009
1,380,690
1,455,049
1,528,328
1,620,368
1,722,132
1,785,357
1,940,865
2,047,821
2,870,807
2,932,458
3,006,971
3,059,732
2,978,544
3,159,416
3,221,241
3,324,593
3,339,255
3,455,628
3,591,107
3,726,172
3,897,636
4,037,241
4,383,523
4,533,150
4,503,115
4,697,734
4,882,225
5,046,309
4,916,703
4,981,063
4,069,750
4,201,179
4,408,171
5,556,206
5,609,632
5,833,421
5,925,116
6,182,294
6,512,959
6,762,038
6,753,151
6,797,988
6,558,842
6,697,649
7,104,323
7,102,584
7,546,549
7,734,761
8,274,116
8,076,555
8,076,5558,274,1167,734,7617,546,5497,102,5847,104,3236,697,6496,558,8426,797,9886,753,1516,762,0386,512,9596,182,2945,925,1165,833,4215,609,6325,556,2064,408,1714,201,1794,069,7504,981,0634,916,7035,046,3094,882,2254,697,7344,503,1154,533,1504,383,5234,037,2413,897,6363,726,1723,591,1073,455,6283,339,2553,324,5933,221,2413,159,4162,978,5443,059,7323,006,9712,932,4582,870,8072,047,8211,940,8651,785,3571,722,1321,620,3681,528,3281,455,0491,380,6901,358,0091,296,9861,248,3341,219,7501,232,2831,191,8401,129,0701,099,7901,123,0771,088,3341,031,9421,014,238991,704960,451930,593902,802899,162872,356856,798835,990831,778798,935771,967815,159815,397784,402765,251726,725713,758685,290658,973639,407622,10980,44072,00964,463
   Common Stock
0
65,000
65,000
100,000
100,000
100,000
100,000
100,000
180,000
180,000
180,000
180,000
234,000
234,000
234,000
234,000
230,966
230,174
230,174
230,174
230,174
230,174
230,174
230,174
299,226
299,226
299,226
299,226
299,226
299,226
299,226
299,226
448,839
448,839
448,839
448,839
538,607
538,607
538,607
538,607
547,447
547,447
547,447
547,951
785,302
785,302
785,302
785,302
785,302
785,653
785,653
785,887
785,887
793,138
793,138
793,138
1,031,079
1,031,079
1,043,050
1,042,560
1,042,560
1,042,490
1,042,490
1,042,490
1,250,988
1,250,839
1,250,839
1,250,839
1,250,839
1,322,371
1,322,371
1,322,371
1,454,608
1,454,608
1,454,608
1,454,608
1,491,755
1,491,756
1,491,756
1,491,756
1,483,475
1,483,475
0
0
1,482,507
0
01,482,507001,483,4751,483,4751,491,7561,491,7561,491,7561,491,7551,454,6081,454,6081,454,6081,454,6081,322,3711,322,3711,322,3711,250,8391,250,8391,250,8391,250,8391,250,9881,042,4901,042,4901,042,4901,042,5601,042,5601,043,0501,031,0791,031,079793,138793,138793,138785,887785,887785,653785,653785,302785,302785,302785,302785,302547,951547,447547,447547,447538,607538,607538,607538,607448,839448,839448,839448,839299,226299,226299,226299,226299,226299,226299,226299,226230,174230,174230,174230,174230,174230,174230,174230,966234,000234,000234,000234,000180,000180,000180,000180,000100,000100,000100,000100,000100,00065,00065,0000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000-28,856-29,565-29,565-51,557-53,267-53,267-57,434-80,263-80,263-81,713-81,713-81,71300000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,078
17,623
15,309
10,305
15,411
22,111
16,394
18,722
18,298
12,607
243,728
243,962
239,286
240,357
236,542
236,491
232,766
225,845
0
0
242,719
0
0242,71900225,845232,766236,491236,542240,357239,286243,962243,72812,60718,29818,72216,39422,11115,41110,30515,30917,62311,0780000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue8,635,358
Cost of Revenue-3,404,303
Gross Profit5,231,0555,231,055
 
Operating Income (+$)
Gross Profit5,231,055
Operating Expense-6,849,330
Operating Income1,786,028-1,618,276
 
Operating Expense (+$)
Research Development922,498
Selling General Administrative1,944,379
Selling And Marketing Expenses-
Operating Expense6,849,3302,866,876
 
Net Interest Income (+$)
Interest Income12,918
Interest Expense-238,434
Other Finance Cost-166,311
Net Interest Income-391,826
 
Pretax Income (+$)
Operating Income1,786,028
Net Interest Income-391,826
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,393,2541,786,028
EBIT - interestExpense = -238,434
1,094,797
1,333,230
Interest Expense238,434
Earnings Before Interest and Taxes (EBIT)-1,631,688
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,393,254
Tax Provision-308,454
Net Income From Continuing Ops1,084,8001,084,800
Net Income1,094,797
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-391,826
 

Technical Analysis of Zhejiang Huahai Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Huahai Pharmaceutical Co Ltd. The general trend of Zhejiang Huahai Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Huahai Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Huahai Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 13.27 < 14.14 < 14.14.

The bearish price targets are: 10.71.

Tweet this
Zhejiang Huahai Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Huahai Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Huahai Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Huahai Pharmaceutical Co Ltd. The current macd is -0.11383047.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Huahai Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zhejiang Huahai Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zhejiang Huahai Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Zhejiang Huahai Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Huahai Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Huahai Pharmaceutical Co Ltd. The current adx is 18.14.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zhejiang Huahai Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Zhejiang Huahai Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Huahai Pharmaceutical Co Ltd. The current sar is 14.08.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zhejiang Huahai Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Huahai Pharmaceutical Co Ltd. The current rsi is 39.12. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Zhejiang Huahai Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Huahai Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Huahai Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Huahai Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Huahai Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Huahai Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Huahai Pharmaceutical Co Ltd. The current cci is -162.67621392.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Zhejiang Huahai Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Huahai Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Huahai Pharmaceutical Co Ltd. The current cmo is -34.37264257.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zhejiang Huahai Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Huahai Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Huahai Pharmaceutical Co Ltd. The current willr is -85.25641026.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Zhejiang Huahai Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Huahai Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Huahai Pharmaceutical Co Ltd.

Zhejiang Huahai Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Huahai Pharmaceutical Co Ltd. The current atr is 0.35303997.

Zhejiang Huahai Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Huahai Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Huahai Pharmaceutical Co Ltd. The current obv is 419,235,582.

Zhejiang Huahai Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Huahai Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Huahai Pharmaceutical Co Ltd. The current mfi is 40.64.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zhejiang Huahai Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Huahai Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Huahai Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Zhejiang Huahai Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Huahai Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.123
Ma 20Greater thanMa 5013.585
Ma 50Greater thanMa 10013.220
Ma 100Greater thanMa 20014.200
OpenGreater thanClose12.760
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Huahai Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Huahai Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Huahai Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Huahai Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Huahai Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Huahai Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Huahai Pharmaceutical Co Ltd in your mailbox!